{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:42:14Z","timestamp":1787316134116,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.cyto.2009.06.003","type":"journal-article","created":{"date-parts":[[2009,7,15]],"date-time":"2009-07-15T05:00:05Z","timestamp":1247634005000},"page":"166-172","source":"Crossref","is-referenced-by-count":39,"title":["Role of proinflammatory markers and NT-proBNP in patients with an implantable cardioverter-defibrillator and an electrical storm"],"prefix":"10.1016","volume":"47","author":[{"given":"Florian","family":"Streitner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juergen","family":"Kuschyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Veltmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desiree","family":"Ratay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Schoene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Streitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Brueckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burghard","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Borggrefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Wolpert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2009.06.003_bib1","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJM199612263352601","article-title":"Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter automatic defibrillator implantation trial investigators","volume":"335","author":"Moss","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cyto.2009.06.003_bib2","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cyto.2009.06.003_bib3","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1053\/euhj.2000.2476","article-title":"Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs implantable defibrillator study. Cardiac arrest study Hamburg. Canadian implantable defibrillator study","volume":"21","author":"Connolly","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cyto.2009.06.003_bib4","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1056\/NEJMra035432","article-title":"Implantable cardioverter-defibrillators","volume":"349","author":"DiMarco","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cyto.2009.06.003_bib5","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0735-1097(98)00495-1","article-title":"Electrical storm in patients with transvenous implantable cardioverter-defibrillators: incidence, management and prognostic implications","volume":"32","author":"Credner","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cyto.2009.06.003_bib6","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/eupc.2000.0104","article-title":"Is electrical storm in ICD patients the sign of a dying heart? Outcome of patients with clusters of ventricular tachyarrhythmias","volume":"2","author":"Greene","year":"2000","journal-title":"Europace"},{"key":"10.1016\/j.cyto.2009.06.003_bib7","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1161\/01.CIR.103.16.2066","article-title":"Electrical storm presages nonsudden death: the antiarrhythmics versus implantable defibrillators (AVID) trial","volume":"103","author":"Exner","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cyto.2009.06.003_bib8","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1542-474X.2007.00187.x","article-title":"Electrical storm in patients with an implanted defibrillator: a matter of definition","volume":"12","author":"Israel","year":"2007","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.cyto.2009.06.003_bib9","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.eupc.2005.01.003","article-title":"Electrical storm is an independent predictor of adverse long-term outcome in the era of implantable defibrillator therapy","volume":"7","author":"Gatzoulis","year":"2005","journal-title":"Europace"},{"key":"10.1016\/j.cyto.2009.06.003_bib10","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1093\/eurheartj\/ehl276","article-title":"Electrical storm in patients with an implantable defibrillator: incidence, features, and preventive therapy: insights from a randomized trial","volume":"27","author":"Hohnloser","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cyto.2009.06.003_bib11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1023\/A:1011462011567","article-title":"The role of anti-cytokine therapy in the failing heart","volume":"6","author":"Deswal","year":"2001","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.cyto.2009.06.003_bib12","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/0735-1097(95)00589-7","article-title":"Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD)","volume":"27","author":"Torre-Amione","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cyto.2009.06.003_bib13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0008-6363(02)00413-3","article-title":"Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in rats","volume":"55","author":"Deten","year":"2002","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cyto.2009.06.003_bib14","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1161\/01.CIR.101.15.1767","article-title":"Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men","volume":"101","author":"Ridker","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cyto.2009.06.003_bib15","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1161\/01.CIR.0000103131.70301.4F","article-title":"Inflammation as a risk factor for atrial fibrillation","volume":"108","author":"Aviles","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cyto.2009.06.003_bib16","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1161\/hc4901.101760","article-title":"C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation","volume":"104","author":"Chung","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cyto.2009.06.003_bib17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ijcard.2006.09.015","article-title":"Inflammatory markers according to types of atrial fibrillation","volume":"120","author":"Gedikli","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cyto.2009.06.003_bib18","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cyto.2007.07.187","article-title":"Prospective study of interleukin-6 and the risk of malignant ventricular tachyarrhythmia in ICD-recipients \u2013 A pilot study","volume":"40","author":"Streitner","year":"2007","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2009.06.003_bib19","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/europace\/eum102","article-title":"hs-C-reactive protein, procollagen to assess the risk of ventricular tachycardia in ICD recipients after myocardial infarction","volume":"9","author":"Blangy","year":"2007","journal-title":"Europace"},{"key":"10.1016\/j.cyto.2009.06.003_bib20","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/hrt.2004.058198","article-title":"Preimplantation B-type natriuretic peptide concentration is an independent predictor of future appropriate implantable defibrillator therapies","volume":"92","author":"Verma","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.cyto.2009.06.003_bib21","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.amjcard.2007.03.074","article-title":"Comparison of N-terminal pro-brain natriuretic peptide versus electrophysiologic study for predicting future outcomes in patients with an implantable cardioverter defibrillator after myocardial infarction","volume":"100","author":"Yu","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cyto.2009.06.003_bib22","first-page":"695","article-title":"Electrical storms in patients with implantable cardioverter-defibrillator: incidence and clinical management","volume":"7","author":"Devecchi","year":"2006","journal-title":"G Ital Cardiol (Rome)"},{"key":"10.1016\/j.cyto.2009.06.003_bib23","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/eurheartj\/ehi726","article-title":"Clinical predictors and prognostic significance of electrical storm in patients with implantable cardioverter defibrillators","volume":"27","author":"Brigadeau","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cyto.2009.06.003_bib24","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1046\/j.1540-8167.2004.04352.x","article-title":"Prevalence, predictors, and mortality significance of the causative arrhythmia in patients with electrical storm","volume":"15","author":"Verma","year":"2004","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.cyto.2009.06.003_bib25","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ejheart.2006.07.004","article-title":"B-type natriuretic peptide levels predict event-free survival in patients with implantable cardioverter defibrillators","volume":"9","author":"Christ","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cyto.2009.06.003_bib26","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1136\/hrt.2005.076117","article-title":"Raised B-type natriuretic peptide predicts implantable cardioverter-defibrillator therapy in patients with ischaemic cardiomyopathy","volume":"92","author":"Klingenberg","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.cyto.2009.06.003_bib27","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0140-6736(96)07591-5","article-title":"Production of C-reactive protein and risk of coronary events in stable and unstable angina","volume":"349","author":"Haverkate","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2009.06.003_bib28","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.amjcard.2006.01.045","article-title":"Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and\/or healed myocardial infarction","volume":"98","author":"Fisman","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cyto.2009.06.003_bib29","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1136\/hrt.2003.028399","article-title":"Sudden unexpected death in heart failure may be preceded by short term, intraindividual increases in inflammation and in autonomic dysfunction: a pilot study","volume":"90","author":"Shehab","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.cyto.2009.06.003_bib30","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1540-8159.2006.00518.x","article-title":"Increased ventricular ectopic activity in relation to C-reactive protein, and NT-pro-brain natriuretic peptide in subjects with no apparent heart disease","volume":"29","author":"Sajadieh","year":"2006","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.cyto.2009.06.003_bib31","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0002-9343(99)00066-2","article-title":"Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly","volume":"106","author":"Harris","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.cyto.2009.06.003_bib32","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1136\/hrt.2005.065771","article-title":"C reactive protein is associated with malignant ventricular arrhythmias in patients with ischaemia with implantable cardioverter-defibrillator","volume":"92","author":"Biasucci","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.cyto.2009.06.003_bib33","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1379\/CSC-272.1","article-title":"Circulating heat shock proteins and inflammatory markers in patients with idiopathic left ventricular dysfunction: their relationships with myocardial and microvascular impairment","volume":"12","author":"Giannessi","year":"2007","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.cyto.2009.06.003_bib34","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1161\/01.CIR.0000017821.98250.25","article-title":"Sudden death predictors: an inflammatory association","volume":"105","author":"Spooner","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cyto.2009.06.003_bib35","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1536\/jhj.45.441","article-title":"C-reactive protein and atrial fibrillation. Is inflammation a consequence or a cause of atrial fibrillation?","volume":"45","author":"Sata","year":"2004","journal-title":"Jpn Heart J"},{"key":"10.1016\/j.cyto.2009.06.003_bib36","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.amjcard.2005.11.052","article-title":"C-Reactive protein in lone atrial fibrillation","volume":"97","author":"Ellinor","year":"2006","journal-title":"Am J Cardiol"},{"issue":"7\u20138","key":"10.1016\/j.cyto.2009.06.003_bib37","first-page":"175","article-title":"Influence of electrical cardioversion on troponine I and brain natriuretic peptide (NT-proBNP) levels in patients with persistent atrial fibrillation\/flutter C-Reactive protein in lone atrial fibrillation","volume":"130","author":"Puljevic","year":"2008","journal-title":"Lijec Vjesn"},{"issue":"3","key":"10.1016\/j.cyto.2009.06.003_bib38","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.resuscitation.2006.02.003","article-title":"Serum cardiac markers response to biphasic and monophasic electrical cardioversion for supraventricular tachyarrhythmia \u2013 a randomised study","volume":"70","author":"Skulec","year":"2006","journal-title":"Resuscitation"},{"key":"10.1016\/j.cyto.2009.06.003_bib39","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.ehj.2004.04.025","article-title":"Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation","volume":"25","author":"Dernellis","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cyto.2009.06.003_bib40","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.ehj.2004.08.001","article-title":"Inflammation, arrhythmia burden and the thrombotic consequences of atrial fibrillation","volume":"25","author":"Conway","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cyto.2009.06.003_bib41","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.cardiores.2005.11.028","article-title":"Prednisone prevents atrial fibrillation promotion by atrial tachycardia remodeling in dogs","volume":"69","author":"Shiroshita-Takeshita","year":"2006","journal-title":"Cardiovasc Res"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104346660900163X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104346660900163X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T05:00:20Z","timestamp":1545109220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104346660900163X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S104346660900163X"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2009.06.003","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}